RxDoctor Payments Data

Alois Zauner, MD

Neurological Surgery · San Diego, CANPI 1922023720

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (50.7%), speaking fees and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Balt USA, LLC at 51.9% of the total. Among neurological surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$557,903in general payments, 2019–2025

Across 218 payments — averaging $2559.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Balt USA, LLC$290K
  • Medtronic$229K
  • Stryker$21K
  • Imperative Care, Inc$8K
  • Qapel Medical Inc$6K
  • Microvention, Inc.$3K
  • plus $422 from 5 others
$201,367in research payments, 2019–2025

Across 35 payments — averaging $5753.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Balt USA, LLC$193K
  • Penumbra, Inc.$5K
  • Medtronic$2K
  • Stryker$2K

What the payments were for

  • Consulting fees$283,03351%
  • Speaking & faculty fees$221,55640%
  • Travel & lodging$4,4711%
  • Food & beverage$7,3941%
  • Education$41,4507%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$557,903 in reported general payments places this provider in the 95th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California

Medicare billing

Part B allowed, 2024
$42,451
Medicare patients
69
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate27$168

Paid to pharmacies, not to this prescriber.

Other neurological surgery in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →